Science Daily -
15 May 2019 19:02
A team recently cataloged the neurological symptoms of patients who had received CAR T-cell therapy to better understand its neurotoxic side effects. While neurological symptoms were prevalent -- 77 percent of patients experienced at least one symptom -- they were also temporary.
Share this Article